CTX administration decreased the expression of ZO‐1, Mucin‐2, Occludin, and Claudin‐1, whereas SCH treatment enhanced the extracellular barrier and elevated the expression of tight junction‐associated proteins, as illustrated in Figures 9 and 10. This evidence concerns the gene CLDN7 and spindle cell hemangioma.